BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2900899)

  • 1. Structure-activity relationships among benextramine-related tetraamine disulfides. Chain length effect on alpha-adrenoreceptor blocking activity.
    Quaglia W; Brasili L; Cristalli G; Giardinà D; Picchio MT; Melchiorre C
    J Med Chem; 1988 Sep; 31(9):1861-6. PubMed ID: 2900899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships among benextramine-related tetraamine disulfides at peripheral alpha-adrenoreceptors.
    Angeli P; Brasili L; Brancia E; Giardinà D; Quaglia W; Melchiorre C
    J Med Chem; 1985 Nov; 28(11):1643-7. PubMed ID: 2999398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N,N''-(dithio-2,1-ethanediyl)bis[N'-(pyrrol-2-ylmethyl)-1, 6,- hexanediamine] (pyrextramine), a new irreversible alpha 1-adrenoreceptor blocking agent of the tetramine disulfide class.
    Brasili L; Angeli P; Brancia E; Melchiorre C
    Eur J Pharmacol; 1984 Aug; 103(1-2):181-4. PubMed ID: 6148255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogues of prazosin that bear a benextramine-related polyamine backbone exhibit different antagonism toward alpha1-adrenoreceptor subtypes.
    Bolognesi ML; Marucci G; Angeli P; Buccioni M; Minarini A; Rosini M; Tumiatti V; Melchiorre C
    J Med Chem; 2001 Feb; 44(3):362-71. PubMed ID: 11462977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships for prazosin and WB 4101 analogues as alpha 1-adrenoreceptor antagonists.
    Giardinà D; Bertini R; Brancia E; Brasili L; Melchiorre C
    J Med Chem; 1985 Sep; 28(9):1354-7. PubMed ID: 2863379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships among di- and tetramine disulfides related to benextramine.
    Alvarez M; Granados R; Mauleón D; Rosell G; Salas M; Sallés J; Valls N
    J Med Chem; 1987 Jul; 30(7):1186-93. PubMed ID: 2885418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular properties of the adrenergic alpha-receptor. I--Structural requirements for specific covalent occupancy by N,N'-bis--(5-aminopentyl)cystamine derivatives.
    Ueda Y; Melchiorre C; Lippert B; Belleau B; Chona S; Triggle DJ
    Farmaco Sci; 1978 Jul; 33(7):479-95. PubMed ID: 33832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiol group may be involved in the irreversible blockade of presynaptic alpha 2-adrenoreceptors by pyrextramine and benextramine in the isolated guinea pig ileum.
    Brasili L; Cassinelli A; Angeli P; Melchiorre C
    Life Sci; 1986 May; 38(18):1633-40. PubMed ID: 2871470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships in prazosin-related compounds. Effect of replacing a piperazine ring with an alkanediamine moiety on alpha 1-adrenoreceptor blocking activity.
    Giardinà D; Brasili L; Gregori M; Massi M; Picchio MT; Quaglia W; Melchiorre C
    J Med Chem; 1989 Jan; 32(1):50-5. PubMed ID: 2562855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of isoxuprine and nylidrin on adrenoreceptors in rat vas deferens.
    Abel PW; Fox AW; Minneman KP
    J Auton Pharmacol; 1985 Sep; 5(3):213-9. PubMed ID: 2997229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptide peptidomimetic antagonists of the neuropeptide Y receptor: benextramine analogs with selectivity for the peripheral Y2 receptor.
    Chaurasia C; Misse G; Tessel R; Doughty MB
    J Med Chem; 1994 Jul; 37(14):2242-8. PubMed ID: 7913507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
    Bolognesi ML; Budriesi R; Chiarini A; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1998 Nov; 41(24):4844-53. PubMed ID: 9822553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of adrenaline-induced platelet aggregation by the alpha-adrenoceptor blocking drug benextramine.
    Belleau B; Benfey BG; Melchiorre C; Montambault M
    Br J Pharmacol; 1982 Jun; 76(2):253-7. PubMed ID: 6124293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The irreversible alpha-blocker benextramine interacts with two different thiol groups.
    Melchiorre C; Gallucci P
    Farmaco Sci; 1983 Dec; 38(12):950-6. PubMed ID: 6141952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships in 1,4-benzodioxan-related compounds. 5. Effects of modification of the side chain on alpha-adrenoreceptor blocking activity.
    Quaglia W; Giannella M; Marucci G; Piergentili A; Pigini M; Tayebati SK; Melchiorre C
    Farmaco; 1996 Jan; 51(1):27-32. PubMed ID: 8721758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.
    Palea S; Corsi M; Rimland JM; Trist DG; Ratti E
    Br J Pharmacol; 1995 Nov; 116(5):2401-6. PubMed ID: 8581275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships in 1,4-benzodioxan-related compounds. Investigation on the role of the dehydrodioxane ring on alpha 1-adrenoreceptor blocking activity.
    Pigini M; Brasili L; Giannella M; Giardinà D; Gulini U; Quaglia W; Melchiorre C
    J Med Chem; 1988 Dec; 31(12):2300-4. PubMed ID: 2903932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
    Minneman KP; Abel PW
    Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
    Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
    J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.